Layer 1
Generics

Refine

E.g., 15/12/2018
E.g., 15/12/2018

Refine

Refine

E.g., 15/12/2018
E.g., 15/12/2018

generics

The Medicines and Healthcare products Regulatory Agency (MHRA) first issued a partial suspension of the manufacturer’s licence in August 2017, after...
27/11/2018 4
EXCLUSIVE
The court dismissed Pfizer’s attempt to prevent generic pregabalin from being used to treat certain types of pain, such as neuropathic pain,...
15/11/2018 0
The Shackleton branch in Abergavenny is relocating to offer more services (Credit: © 2017 Google, image capture: April 2017)
Pre-tax profit for the independent H Shackleton chain in the 12 months to October 2017 fell from £496,000 to £422,000, with half the loss due to the...
14/08/2018 14
Health secretary Matt Hancock announced last week that he had “asked the Department of Health and Social Care (DH) for options for stockpiling”...
02/08/2018 7
EXCLUSIVE
DH: Revealing commercially sensitive data could damage our ability to set reimbursement prices
A National Audit Office (NAO) report into last year’s “unexpected increase” in generics prices – published last month (June 8) – referred to...
16/07/2018 10
DH was among organisations called to face a government committee over generics price increases
Representatives from pharmacy, the Department of Health and Social Care (DH) and NHS England were called in front of the Public Accounts Committee –...
12/07/2018 2
EXCLUSIVE
HDA: Members handle more than 90% of NHS medicines but only represent 20 out of 2,100 licences
A National Audit Office (NAO) investigation last week (June 8) into generics prices referred to government evidence of “unexpected increases in...
13/06/2018 3
It's good that the National Audit Office (NAO) has looked at the issue of NHS spending on generic medicines in primary care, because I think many...
11/06/2018 5
The NAO launched its investigation – the results of which were published today (June 8) –  to find out why “significant unbudgeted pressure” had been...
07/06/2018 7
BGMA: Up to 120 products were affected by the suspension of two supplier's manufacturing licences
Last September, the Pharmaceutical Services Negotiating Committee (PSNC) announced it was in "urgent discussions" with the Department of Health and...
08/05/2018 1

Pages